During the past decade, Seton Heart Institute conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 5 clinical trials were completed, i.e. on average, 38.5% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Seton Heart Institute" #1 sponsor was "Bayer" with 2 trials, followed by "Amgen" with 1 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Boston Scientific Corporation" with 1 trials sponsored and "C. R. Bard" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Seton Heart Institute" #1 collaborator was "Chiltern International Inc." with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "The Cleveland Clinic" with 1 trials as a collaborator and "United States Department of Defense" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Seton Heart Institute" are "Arterial Occlusive Diseases" (2 trials), "Coronary Artery Disease" (2 trials), "Heart Failure" (2 trials), "Peripheral Arterial Disease" (2 trials) and "ASCVD" (1 trials). Many other conditions were trialed in "Seton Heart Institute" in a lesser frequency.

Most popular intervention types in "Seton Heart Institute" are "Drug" (7 trials), "Device" (4 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "ACE-I (lisinopril) or ARB (losartan)" (1 trials), "Aspirin" (1 trials), "Bempedoic acid 180 mg tablet" (1 trials) and "Edoxaban-based Regimen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Seton Heart Institute" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Seton Heart Institute". undefined are not yet recruiting, 2 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Seton Heart Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Seton Heart Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".